Molly Harper Catalyst Pharmaceuticals, Inc. (CPRX) insider trading activity

CPRX Quotes by TradingView

Molly Harper is Director of CATALYST PHARMACEUTICALS, INC.. Currently has a direct ownership of 0 shares of CPRX, which is worth approximately $0. The most recent transaction as insider was on Jun 03, 2024, when has been sold 5,333 shares (Common Stock, par value $0.001 per share) at a price of $16.3 per share, resulting in proceeds of $86,927. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
100.0% 12M change
Total Value Held $0

Molly Harper Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 03 2024
SELL
Open market or private sale
$86,927 $16.3 p/Share
5,333 Reduced 100.0%
0 Common Stock, par valu...
Feb 15 2024
BUY
Exercise of conversion of derivative security
-
4,000 Added 42.86%
5,333 Common Stock, par valu...
Dec 27 2023
BUY
Exercise of conversion of derivative security
-
1,333 Added 50.0%
1,333 Common Stock, par valu...
Dec 15 2023
SELL
Open market or private sale
$201,600 $14.4 p/Share
14,000 Reduced 100.0%
0 Common Stock, par valu...
Dec 15 2023
BUY
Exercise of conversion of derivative security
$57,800 $5.78 p/Share
10,000 Added 50.0%
10,000 Common Stock, par valu...
Feb 15 2023
BUY
Exercise of conversion of derivative security
-
4,000 Added 50.0%
4,000 Common Stock, par valu...
MH

Molly Harper

Director
Coral Gables, FL

Track Institutional and Insider Activities on CPRX

Follow CATALYST PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CPRX shares.

Notify only if

Insider Trading

Get notified when an Catalyst Pharmaceuticals, Inc. insider buys or sells CPRX shares.

Notify only if

News

Receive news related to CATALYST PHARMACEUTICALS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CPRX